Juan Esteban Gómez‐MesaJuliana María Gutiérrez‐PossoManuela Escalante‐ForeroBrayan Daniel Córdoba‐MeloPaula Andrea Cárdenas‐MarínEduardo PernaMádelyn Raquel Valle‐RamosGermán Camilo GiraldoNoel A. Flórez-AlarcónIda Fabiola Rodríguez Caballero2026-03-222026-03-22202310.1002/clc.24182https://doi.org/10.1002/clc.24182https://andeanlibrary.org/handle/123456789/46047Citaciones: 10AMERICCAASS is the first continental registry to include hospitalized or outpatient patients with HF. Regarding optimal medical therapy, approximately a quarter of the patients still need to receive BB and ACEI/ARB/ARNI, less than half do not receive MRA, and more than two-thirds do not receive SGLT2i.enMedicineHeart failureInterquartile rangeInternal medicineDecompensationAmbulatorySpironolactoneCardiologyarticle